Application no. and date | 01203170.4 (espacenet) (Federated) (European Patent Register), 19960620 | Patent/reg. no. and date | DK/EP 1174135, 20090805 | Publication date | 20020123 | Priority no. and date | JP 15350095, 19950620 | EP pub. no. and date |
EP 1174135 20020123 | Effective date | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku Osaka 541-0045, JP | Applicant ref. no. | 151760 | Inventor | Ikeda, Hitoshi, 3-13-712 Nishiiwata 3-chome
Higashiosaka,
Osaka 578, JP, Sohda, Takashi, 27-20 Higashikanmaki 2-chome
Takatsuki,
Osaka 569, JP, Odaka, Hiroyuki, 12-12 Katsuragi 2-chome,
Kita-ku
Kobe,
Hyogo 651-12, JP | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61K 31/64 (2006.01) | Title | Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2009 00045 | Status | Ændret EP patent ikke valid i DK | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|